Form 4: Repligen CFO Jason K. Garland Reports Stock and Option Awards
SEC Form 4 Filing
Repligen's CFO, Jason K. Garland, reports the acquisition of restricted stock units and stock options, as well as the disposal of common stock.
Summary
- On March 3, 2025, Jason K. Garland, CFO of Repligen Corp, reported transactions involving Repligen's stock.
- Garland was awarded 6,435 restricted stock units (RSUs), each representing a contingent right to receive one share of Repligen's common stock.
- These RSUs vest in equal annual installments over three years, starting on the first anniversary of the grant date.
- Garland also acquired 6,056 stock options with an exercise price of $155.38.
- One third of these options will vest annually on March 3, 2026, March 3, 2027, and March 3, 2028.
- Additionally, Garland disposed of 6,435 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The grant of RSUs and stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to improve company performance.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates compensation and ownership changes for a key executive at Repligen.
Stakeholder Impact
- The transactions reported may influence investor perception of Repligen's stock, as insider activity is often monitored for signals about company performance.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of transaction: Grant of restricted stock units and stock options, and disposal of common stock. |
| 03/03/2026 | First vesting date for one-third of the stock options. |
| 03/03/2027 | Second vesting date for one-third of the stock options. |
| 03/03/2028 | Third vesting date for one-third of the stock options. |
| 03/03/2035 | Expiration date of the stock options. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.